Literature DB >> 35371524

Optimal timing of radiotherapy following brain metastases surgery.

Nasser K Yaghi1, Stephanie Radu1, Joseph G Nugent1, David J Mazur-Hart1, Brandi W Pang1, Stephen G Bowden1, Blair Murphy2, Seunggu J Han3.   

Abstract

Background: There is growing evidence supporting the need for a short time delay before starting radiotherapy (RT) treatment postsurgery for most optimal responses. The timing of RT initiation and effects on outcomes have been evaluated in a variety of malignancies, but the relationship remains to be well established for brain metastasis.
Methods: Retrospective study of 176 patients (aged 18-89 years) with brain metastases at a single institution (March 2009 to August 2018) who received RT following surgical resection. Time interval (≤22 and >22 days) from surgical resection to initiation of RT and any potential impact on patient outcomes were assessed.
Results: Patients who underwent RT >22 days after surgical resection had a decreased risk for all-cause mortality of 47.2% (95% CI: 8.60, 69.5%). Additionally, waiting >40 days for RT after surgical resection more than doubled the risk of tumor progression; adjusted hazard ratio 2.02 (95% CI: 1.12, 3.64). Conclusions: Findings indicate that a short interval delay (>22 days) following surgical resection is required before RT initiation for optimal treatment effects in brain metastasis. Our timing of RT postsurgical resection data adds definition to current heterogeneity in RT timing, which is especially important for standardized clinical trial design and patient outcomes.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  adjuvant therapy; brain metastasis; postoperative; radiation; treatment timing

Year:  2022        PMID: 35371524      PMCID: PMC8965066          DOI: 10.1093/nop/npac007

Source DB:  PubMed          Journal:  Neurooncol Pract        ISSN: 2054-2577


  20 in total

1.  Epidemiology of brain metastases.

Authors:  Lakshmi Nayak; Eudocia Quant Lee; Patrick Y Wen
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

2.  Postsurgical Cavity Evolution After Brain Metastasis Resection: How Soon Should Postoperative Radiosurgery Follow?

Authors:  Rajal A Patel; Derrick Lock; Irene B Helenowski; James P Chandler; Sean Sachdev; Matthew C Tate; Tim J Kruser
Journal:  World Neurosurg       Date:  2017-11-06       Impact factor: 2.104

3.  The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma.

Authors:  Seunggu J Han; W Caleb Rutledge; Annette M Molinaro; Susan M Chang; Jennifer L Clarke; Michael D Prados; Jennie W Taylor; Mitchel S Berger; Nicholas A Butowski
Journal:  Neurosurgery       Date:  2015-08       Impact factor: 4.654

4.  A randomized trial of surgery in the treatment of single metastases to the brain.

Authors:  R A Patchell; P A Tibbs; J W Walsh; R J Dempsey; Y Maruyama; R J Kryscio; W R Markesbery; J S Macdonald; B Young
Journal:  N Engl J Med       Date:  1990-02-22       Impact factor: 91.245

5.  Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification.

Authors:  Robert H Press; Sarah L Shafer; Renjian Jiang; Zachary S Buchwald; Mustafa Abugideiri; Sibo Tian; Tiffany M Morgan; Madhusmita Behera; Soma Sengupta; Alfredo D Voloschin; Jeffrey J Olson; Shaakir Hasan; Deborah T Blumenthal; Walter J Curran; Bree R Eaton; Hui-Kuo G Shu; Jim Zhong
Journal:  Cancer       Date:  2020-04-28       Impact factor: 6.860

6.  Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

Authors:  R A Patchell; P A Tibbs; W F Regine; R J Dempsey; M Mohiuddin; R J Kryscio; W R Markesbery; K A Foon; B Young
Journal:  JAMA       Date:  1998-11-04       Impact factor: 56.272

Review 7.  Surgical management of brain metastases.

Authors:  Moksha G Ranasinghe; Jonas M Sheehan
Journal:  Neurosurg Focus       Date:  2007-03-15       Impact factor: 4.047

8.  Durable 5-year local control for resected brain metastases with early adjuvant SRS: the effect of timing on intended-field control.

Authors:  Evan D Bander; Melissa Yuan; Anne S Reiner; Katherine S Panageas; Åse M Ballangrud; Cameron W Brennan; Kathryn Beal; Viviane Tabar; Nelson S Moss
Journal:  Neurooncol Pract       Date:  2021-01-21

9.  Pre-Operative Versus Post-Operative Radiosurgery of Brain Metastases-Volumetric and Dosimetric Impact of Treatment Sequence and Margin Concept.

Authors:  Rami A El Shafie; Eric Tonndorf-Martini; Daniela Schmitt; Dorothea Weber; Aylin Celik; Thorsten Dresel; Denise Bernhardt; Kristin Lang; Philipp Hoegen; Sebastian Adeberg; Angela Paul; Jürgen Debus; Stefan Rieken
Journal:  Cancers (Basel)       Date:  2019-03-01       Impact factor: 6.639

10.  Infarct volume after glioblastoma surgery as an independent prognostic factor.

Authors:  Stefanie Bette; Benedikt Wiestler; Johannes Kaesmacher; Thomas Huber; Julia Gerhardt; Melanie Barz; Claire Delbridge; Yu-Mi Ryang; Florian Ringel; Claus Zimmer; Bernhard Meyer; Tobias Boeckh-Behrens; Jan S Kirschke; Jens Gempt
Journal:  Oncotarget       Date:  2016-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.